Current opinion in oncology
-
To provide an update on novel compounds in head and neck cancer (HNC) therapy, with emphasis on biologic agents. ⋯ New molecular-targeted therapies are inducing consistent, small improvements in HNC management. The major challenge regards how to better combine them with the final aim of obtaining long-term stabilization of advanced disease.